Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Continuous Manufacturing (Small Molecules and Biologics) Market (2nd Edition), 2022-2035
... manufacturing. Continuous manufacturing, also known as continuous flow chemistry, is an advanced manufacturing technology, which drives operations in a continuous manner (24×7) in one facility, without hold times. The concept was first described in the ... Read More
-
2023 Global Advanced Wound Care Biologics Market Industry (2029 Outlook)
... Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product ... Read More
-
Global Bioreactors and Fermenters Market, 2023-2035
... which are otherwise hard to treat. In fact, in the past two decades, over 170 biopharmaceuticals have already been granted approval by the FDA and over 7,500 biological interventions are under evaluation in clinical trials.It ... Read More
-
Digital Biomanufacturing Market - Distribution by Type of Technology, Deployment Options, Types of Biologics Manufactured, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035
... immense pressure on the biopharmaceutical industry to reduce production timelines and increase the manufacturing capacity, without compromising on the quality of the final product. Further, a surge in morbidity across the globe and enhanced interconnectivity ... Read More
-
2023 Global Bioanalytical Testing Services Market Industry (2029 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include ... Read More
-
Biopharmaceutical Excipient Manufacturing Market by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers / Surfactants, Polyols, Proteins / Amino Acids and Others, Company Size (Small, Mid-sized, Large / Very Large), Scale of Operation (Preclinical, Clinical and Commercial) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2022-2035
... / Very Large), Scale of Operation (Preclinical, Clinical and Commercial) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2022-2035 Over the years, the rising popularity ... Read More
-
Global Biologics Fill Finish Service Market Growth (Status and Outlook) 2023-2029
... expected to grow at a CAGR of % from 2023 to 2029. United States market for Biologics Fill Finish Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Global Biologics Safety Testing Service Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of 12.1% from 2023 to 2029. United States market for Biologics Safety Testing Service is estimated to increase from US$ million in 2022 to US$ million by ... Read More
-
Global Biosimilars Market - 2023-2030
... is expected to exhibit a CAGR of 12.8% during the forecast period 2023-2030. Biosimilars provide an opportunity to increase patient access to biological therapies by offering more affordable alternatives while maintaining the same therapeutic benefits. ... Read More
-
2023 Global Forecast for Oncology Biosimilars Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Drug Discovery Services Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Chemistry Services, Biology Services); By Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization); By Drug Type (Biologics, Small Molecule Drugs); By Therapeutic Area (Neurology, Infectious & Immune System Diseases, Digestive System Diseases, Oncology, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Drug Type (Biologics, Small Molecule Drugs); By Therapeutic Area (Neurology, Infectious & Immune System Diseases, Digestive System Diseases, Oncology, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Region (North America, Europe, ... Read More
-
Automation in Biopharmaceutical Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
Biologics Contract Development Market Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication (Oncology, Immunological Disorders), By Region And Segment Forecasts, 2023 - 2030
... report by Grand View Research, Inc. Key drivers attributed to the growth include rising adoption of advanced technologies by biologics manufacturers, M&A, and clinical trials in developing nations.The market includes organizations that offer services such ... Read More
-
Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence
... continues to examine the impact of inflation on healthcare systems, patients, and HCPs. The report provides an overview of the current and future outlook of the healthcare sector, government policies, innovative technologies, and initiatives that ... Read More
-
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028
... billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% during the forecast period. Factors such as regulatory approvals, favorable reimbursement policies, rising demand for cost effective biosimilars is driving the ... Read More
-
Spine Biologics Market (Product: Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy, Demineralized Bone Matrix (DBM), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global Spine Biologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Membrane Bioreactor (MBR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 10% during 2023-2028. A membrane bioreactor (MBR) is primarily used for industrial and municipal wastewater treatment. It is an integration of a perm-selective ... Read More
-
Global Biologics Water-free Thawing System Market Growth 2023-2029
... at a CAGR of % from 2023 to 2029. To date many Cell Therapy companies have understandably focused on testing the effects of their products in small scale manufacturing which may not require cryopreservation. As ... Read More
-
Global Retinal Biologics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... Retinal biologics refer to bioengineered molecules which are implanted inside the eyes in order to heal chronic retinal diseases. Market Overview: The latest research study on the global Retinal Biologics market finds that the global ... Read More
-
Bioprocess Technology Market Size and Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
... User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others) The bioprocess technology market size is expected to grow from US$ 30.89 billion in 2022 to US$ 77.09 billion by 2028. The market is ... Read More
-
Global Cell Line Development for Biologics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were ... Read More
-
Global Biologics and Biosimilars Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... million in 2022 and is forecast to a readjusted size of USD 843370 million by 2029 with a CAGR of 8.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while ... Read More
-
Global Biologics and Biosimilars Supply, Demand and Key Producers, 2023-2029
... the forecast period (2023-2029). Global key biologics and biosimilars manufacturers include Johnson & Johnson, Pfizer, Roche, Amgen, AbbVie, and others. The top five manufacturers together account for approximately 50% of the market share, with the ... Read More
-
Global Lucentis (Ranibizumab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -2.7% from 2023 to 2029. United States market for Lucentis (Ranibizumab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Humira Biosimilar Market Growth 2023-2029
... CAGR of 13.0% from 2023 to 2029. The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars ... Read More
Research Assistance
